Improved economic and clinical outcomes with oritavancin versus a comparator group for treatment of acute bacterial skin and skin structure infections in a community hospital

BACKGROUND: Oritavancin is a lipoglycopeptide antibiotic with in vitro bactericidal activity against gram-positive pathogens indicated for use in adults with acute bacterial skin and skin structure infections (ABSSSI). Its concentration-dependent activity and prolonged half-life provide a convenient...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:PLoS One
Autors principals: Saddler, Kimberly, Zhang, Jason, Sul, Jennifer, Patel, Pruthvi, Castro-Lainez, Miriams, Stevens, Mark L., Kosler, Sheryl, Lowery, Emily, Sierra-Hoffman, Miguel
Format: Artigo
Idioma:Inglês
Publicat: Public Library of Science 2021
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7971560/
https://ncbi.nlm.nih.gov/pubmed/33735185
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0248129
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars